ANZUP actively engages, collaborates, and expands its stakeholder relationships through various means. Crucially, the funding agreement with the Australian Government through the Cancer Australia Support for Clinical Trials continues to support ANZUP’s infrastructure.

Donors, volunteers, philanthropists, corporate partners, and other key stakeholders remain a significant focus for ANZUP and especially the Partnerships and Engagement role. ANZUP continues to develop, manage and retain these important relationships.

Collaborative links have played a significant role in ANZUP’s ability to operate at a high capacity. This is demonstrated by the four co-badged trials with other Cancer Cooperative Trials Groups (CCTGs) and our membership of the Executive Officers Network (EON) and Clinical Trials Consumer Network (CTCN). The CTCN shares information amongst the groups’ Consumer Advisory Panels (CAPs) and EON reinforces links between groups by the sharing of concepts and resources.

In 2022/23, ANZUP collaborated with the NHMRC Clinical Trials Centre (CTC) at the University of Sydney to conduct 10 clinical trials. In addition, ANZUP partnered with the Centre for Biostatistics and Clinical Trials (BaCT) to conduct 4 clinical trials and with the Walter and Eliza Hall Institute of Medical Research (WEHI) for 1 trial. These established affiliations guarantee vigorous processes on trial development and operations.

ANZUP’s Key Relationships include: